Sergio Marchini, Researcher at Humanitas Research Hospital, shared a post on LinkedIn:
“Today I had the pleasure of being at the headquarters of Fondazione Alessandra Bono to discuss how genomics is opening new avenues for the early diagnosis of ovarian cancer and for the development of advanced liquid biopsy approaches to monitor patients over time.
Integrating high-resolution genomic technologies with translational research is key to improving sensitivity, anticipating relapse, and ultimately moving toward more precise and personalized disease management.”
Other articles on OncoDaily.
